Actos & Diabetes Drugs Containing Pioglitazone

If you’ve taken Actos, ActoPlus Met, ActoPlus Met XR, or Duetact and experienced serious side effects, you’re not alone.

Actos and other medications containing pioglitazone is a prescription medication used with diet and exercise to improve glucose (blood sugar) control in adults with type 2 diabetes.  Unfortunately, multiple medical studies have linked have linked Actos and other Type 2 diabetes medications containing pioglitazone with the onset of bladder cancer.  According to a Food and Drug Administration (FDA) warning concerning Actos and bladder cancer, patients taking pioglitzone, an ingredient found in these diabetes drugs, for more than a year may have an increased risk of developing cancerous tumors of the bladder.

In several lawsuits filed against Takeda and Eli Lilly Pharmaceuticals (makers of Actos), it has been alleged the these pharmaceutical companies failed to warn the public about potentially harmful or life-threatening side effects and even willfully concealed or withheld information that Actos posed an increased risk of bladder cancer.  Recently, Takeda Pharmaceutical Co. and Eli Lilly & Co. failed to convince a judge to throw out a combined $9 billion punitive damage jury award over claims the drugmakers deliberately hid the cancer risks their diabetes drug, Actos, posed to users.

If you or a loved one was prescribed Actos, ActoPlus Met, ActoPlus Met XR, or Duetact, and have been diagnosed with bladder cancer or other serious side effect please call us today.  During your free consultation, we’ll let you know all of your options and give you the guidance you need.

The Huntsville, AL personal injury and product liability lawyers at Martinson & Beason want to help you get justice for your pain and suffering.  Your claim could compensate you for your hospital bills, surgical expenses, emotional trauma, and other losses.